ESRRA and metabolic dysfunction-associated steatohepatitis: To examine whether ERRα is a main metabolic effector of NASH development, we injected Fbxw7L−/− mice with C29, which resulted in significantly reduced hepatic neutral fat and TG contents upon clearance of excessive ERRα protein (Fig. 8h, i and Supplementary Fig. 7j).